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The photoreceptor cells of the retina are subject to a greater number of genetic diseases than any other cell type in the human
body. The majority of more than 120 cloned human blindness genes are highly expressed in photoreceptors. In order to
establish an integrative framework in which to understand these diseases, we have undertaken an experimental and
computational analysis of the network controlled by the mammalian photoreceptor transcription factors, Crx, Nrl, and Nr2e3.
Using microarray and in situ hybridization datasets we have produced a model of this network which contains over 600 genes,
including numerous retinal disease loci as well as previously uncharacterized photoreceptor transcription factors. To elucidate
the connectivity of this network, we devised a computational algorithm to identify the photoreceptor-specific cis-regulatory
elements (CREs) mediating the interactions between these transcription factors and their target genes. In vivo validation of our
computational predictions resulted in the discovery of 19 novel photoreceptor-specific CREs near retinal disease genes.
Examination of these CREs permitted the definition of a simple cis-regulatory grammar rule associated with high-level
expression. To test the generality of this rule, we used an expanded form of it as a selection filter to evolve photoreceptor CREs
from random DNA sequences in silico. When fused to fluorescent reporters, these evolved CREs drove strong, photoreceptor-
specific expression in vivo. This study represents the first systematic identification and in vivo validation of CREs in
a mammalian neuronal cell type and lays the groundwork for a systems biology of photoreceptor transcriptional regulation.
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Network. PLoS ONE 2(7): e643. doi:10.1371/journal.pone.0000643
INTRODUCTION
Transcriptional regulatory networks (TRNs) lie at the center of
organismal development and physiology [1,2]. Transcription
factors (TFs) within these networks control the spatiotemporal
pattern and levels of expression of their target genes by binding to
CREs, short (,300–600 bp) stretches of genomic DNA which can
lie upstream, downstream, or within the introns of the genes they
control. Significant progress has been made in the computational
identification of putative CREs in a variety of species [3–7]. One
recent study demonstrated the effectiveness of using deep
phylogenetic conservation of non-coding DNA to identify de-
velopmentally active CREs in the mouse [4]. However, given the
importance of cis-regulatory change in evolution [8] and the
relatively limited number of deeply conserved non-coding regions
in the mouse (,3000 were identified in [4]), it is likely that there are
many tissue-specific CREs which do not fall within such regions.
Despite advances in the design of computational algorithms to
identify CREs in mammalian genomes, the development of cheap,
high-throughput assay systems for validating these computational
predictions in vivo has lagged far behind. Most studies of
mammalian cis-regulation to date have relied on mouse transgen-
esis as a means of assaying the enhancer function of CREs [4].
This technique is time-consuming, costly and subject to insertion
site effects. On the other hand, rapid assays for mammalian CRE
function have been developed in tissue culture systems, but it is not
clear how such results translate into the in vivo behavior of CREs.
We aim to demonstrate in this paper that rapid, inexpensive, high
throughput analysis of mammalian CREs can be achieved by
exploiting electroporation to introduce CRE-reporter fusion
constructs either into living tissue in vivo or in ex vivo explant
culture. This approach retains many of the desirable features of in
vivo transgenic approaches to CRE analysis but is much more
rapid and inexpensive.
Photoreceptor cells are sensory neurons that elaborate a highly
specialized, membrane-rich organelle, the outer segment, which is
exquisitelysensitivetolight.Thesecellsareparticularlysusceptibleto
degeneration. There are currently over 180 mapped disease loci
which cause blindness in humans (http://www.sph.uth.tmc.edu/
RetNet/). Of these, more than 120 have been cloned, and the
majority of these genes have been shown to be specifically expressed,
or highly enriched, in photoreceptors [9]. Unfortunately, there is
currently no systems-level understanding of how transcriptional
regulation of these disease genes is globally coordinated.
We aim to provide such understanding via analysis of the mouse
photoreceptor transcriptional network. Numerous prior studies
have demonstrated a central role in this network for the TFs Crx,
Nrl, and Nr2e3 [10–15]. Crx is expressed in both rods and cones
and activates numerous genes in both [9–11,16]. Nrl and Nr2e3,i n
contrast, are rod-specific and are required for activation of rod
genes and repression of cone genes [13,15,17–20]. Nrl appears to
be a molecular switch between cone and rod cell fate: if
a photoreceptor precursor expresses Nrl it becomes a rod,
otherwise it becomes a cone [21]. All three genes have been
implicated in a variety of blinding diseases in humans [14,22,23].
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PLoS ONE | www.plosone.org 1 July 2007 | Issue 7 | e643Previous studies of mice with mutations in these TFs identified
a range of potential target genes [9,18,20,24,25].
Here, we present a more complete analysis of the genes affected
by these mutations in order to define the nodes of the photo-
receptor TRN. To understand how gene expression in this
network is orchestrated, we identified and characterized many of
the CREs linking these nodes via a combination of computational
prediction and in vivo validation using electroporation of CRE-
reporter fusion constructs. This analysis resulted in the identifica-
tion of a cis-regulatory motif associated with high-level expression
in photoreceptors. To test the importance of this motif for
photoreceptor expression, a selection filter based on this motif was
used to evolve photoreceptor-specific CREs in silico, and their
functional activity was then demonstrated in photoreceptors. This
study demonstrates the feasibility of a high throughput, in vivo,
non-transgenic approach to mammalian CRE analysis which can
easily be applied to a wide range of different tissues.
RESULTS
The transcriptional network controlled by Crx, Nrl,
and Nr2e3
In order to elucidate the global architecture of transcriptional
regulation in mouse photoreceptors, analyses of genes expressed in
Crx
-/- retinas at P21 were carried out on Affymetrix microarrays.
These data were integrated with those of previous studies of Nrl
-/-
and Nr2e3
-/- retinas [20,25]. Using stringent criteria to define
up- and downregulation, a total of 628 genes were identified as
dysregulated in at least one of the three mutants (Fig. 1A; Tables
S1, S2, S3, S4, S5 and S6). 179 genes were downregulated in Crx
-/-
(compared to 140 in Nrl
-/- and 12 in Nr2e3
-/-) whereas 93 genes
were upregulated (compared to 297 in Nrl
-/- and 55 in Nr2e3
-/-).
Our results accord well with two previous gene expression studies
of the Crx mutant using cDNA microarrays and SAGE [9,16]. The
dysregulated genes comprise many known photoreceptor genes
including numerous components of both rod and cone photo-
transduction cascades.
A remarkable degree of overlap between genes downregulated
in Crx
-/- and Nrl
-/- was discovered. 51% (72/140) of Nrl-
downregulated genes were also downregulated in Crx
-/- using
stringent criteria (Fig. 1A). These results suggest that many
photoreceptor genes are co-regulated by Crx and Nrl and are
consistent with previous studies of individual photoreceptor genes
showing co-regulation by these two TFs [26,27]. To analyze the
effects of removing Crx, Nrl, and Nr2e3 activity from the retina
simultaneously, Crx
-/-;Nrl
-/- double mutant mice were generated
and their retinas were subjected to microarray analysis at P21.
Since Nr2e3 is not expressed in Nrl
-/- [13], these mice are
effectively Crx
-/-;Nrl
-/-;Nr2e3
-/-. We found an even greater number
of downregulated genes in the double mutant (298) than in either
of the single mutants using similar criteria (Table S2). This finding
further confirms the status of these TFs as major hubs within the
photoreceptor TRN.
In order to validate the microarray results, we carried out ISH
with probes against 76 photoreceptor genes (,10% of the genes in
the proposed network) on four mutant (Nr2e3
-/-, Crx
-/-, Nrl
-/- , and
Crx
-/-;Nrl
-/-) and two wild-type (C57BL/6 and 129S6/SvEv)
backgrounds. The results for Nrl
-/- and a subset of the results for
Nr2e3
-/- were reported previously [20,25] and are reproduced here
for comparison. The ISH results directly reflected the changes
seen by microarray for nearly all of the genes and genotypes
examined. An exception was that five of the probes examined
showed a greater degree of downregulation in Crx
-/- than was
predicted by microarray (see Table S1). This discrepancy may
relate to the fact that the ISH was performed on retinas from
a somewhat later timepoint (4–5 weeks postnatal) than when the
microarray was performed.
Several examples of ISHs for genes residing at points of
intersection in the Venn diagram in Fig.1A are shown in Fig. 1C-F
(the full intersection dataset is given in Table S7). Rho, which is
typical of genes co-regulated by Crx and Nrl, shows marked
downregulation in both of these mutants as well as in Crx
-/-;Nrl
-/-
(Fig. 1C). Many cone genes such as Gnb3 were upregulated in both
Nrl
-/- and Crx
-/- (Fig. 1D). In contrast, some cone genes such as
Opn1sw were upregulated in Nrl
-/- and downregulated in Crx
-/-
(Fig. 1E). The reason for this difference is not known. A minority
of photoreceptor-specific genes such as Pdc were not changed in
any of the mutants (Fig. 1F), suggesting the possibility of regulation
by other TFs. ISH results for all 76 genes are presented in Table
S1 and Fig. S1. Overall, these results show that the microarray
data are a powerful predictor of photoreceptor gene expression
patterns.
Downstream transcription factors and retinal
disease genes in the photoreceptor network
Given the importance of TFs as regulatory nodes within TRNs we
subjected all 628 genes in our network to Gene Ontology (GO)
analysis to identify those downstream TFs which were dysregu-
lated in Crx
-/-, Nrl
-/- or Nr2e3
-/- retinas. Out of 27 genes with the
GO classification ‘‘transcription factor activity’’, we identified 17
sequence-specific TFs (Table S8). Aside from Crx, Nrl, and Nr2e3,
this set included two known photoreceptor TFs: Otx2 and Rxrg.
Otx2 was previously shown to be required for photoreceptor
formation in the mouse and to activate Crx transcription [28].
Derepression of Otx2 in both Crx
-/- and Crx
-/-;Nrl
-/- suggests that it
is under negative feedback regulation by Crx (Fig. 1J). Rxrg is
required for regulation of S-cone opsin in mice [29] and is also
upregulated in Nrl
-/-. Neurod1 mutant photoreceptors undergo
degeneration suggesting a role for this TF in photoreceptor gene
regulation [30]. Although not in the GO list, we also found Neurod1
to be upregulated in Nrl
-/- (Table S1). Derepression of Neurod1 and
Rxrg in Nrl
-/- suggests that both genes are cone-enriched in the
adult. Surprisingly, Nrl itself was downregulated in Crx
-/- both by
microarray and ISH (Fig. 1 and Table S1), suggesting a re-
quirement for Crx in maintenance of Nrl expression.
Aside from Nrl, Nr2e3 is the only known rod-specific TF. Yet,
the microarray data suggest that Esrrb and Mef2c are also rod-
enriched (Fig. 1G, K). Esrrb is an orphan nuclear receptor required
for placental development and maintenance of ‘‘stemness’’ in
embryonic stem cells and germ cells [31-33]. Although previously
shown to be photoreceptor-enriched [34], complete loss of
expression in Nrl
-/- strongly suggests that Esrrb is rod-specific in
the adult. Mef2c is required for heart development [35]. It was
markedly downregulated in both Crx
-/- and Nrl
-/- by microarray
suggesting that it too might be rod-enriched in the adult. Prdm1,
also known as Blimp-1, is a well known regulator of B-cell and
germ cell differentiation [36-38]. We found that Prdm1 is expressed
at high levels in developing photoreceptors in a pattern in-
distinguishable from Crx itself (Fig. 1H, I). In contrast to Crx, Prdm1
expression is undetectable in the adult wild-type retina. In-
triguingly, homeodomain-containing TFs on either side of the Crx
locus were also dysregulated: Obox6 (upregulated in Crx
-/-) and
Crxos1 (upregulated in Nrl
-/-). The latter result suggests that Crxos1,
previously reported as a possible antisense regulator of Crx [39], is
cone-enriched. Overall, these findings implicate a range of TFs in
regulation of photoreceptor gene expression downstream of Crx
and Nrl.
Photoreceptor Gene Network
PLoS ONE | www.plosone.org 2 July 2007 | Issue 7 | e643Given the remarkable genetic heterogeneity of human retinal
disease, we wished to determine the extent to which the causative
genes are regulated by Crx, Nrl, and Nr2e3. A set of 58 mouse
orthologs of human retinal disease genes from the Retnet database
were manually curated (Fig. 2). This set is meant to encompass all
disease genes with known or probable photoreceptor-enriched
patterns of expression based on analysis of the literature. 89% (50/
56) of those disease genes for which microarray data were available
Figure 1. The transcription network controlled by Crx, Nrl, and Nr2e3. A, Venn diagram summarizing all genes dysregulated under high stringency
criteria. A complete list of dysregulated genes is given in Table S2. The identity of all genes at points of intersection (including additional intersections
not depicted here) are given in Table S7. B, Summary of rod-specific and cone-specific ISH patterns relative to a hematoxylin-eosin (H&E) stained
section of retina. The scleral side of the retina is oriented up in all subsequent images. ONL=outer nuclear layer; INL=inner nuclear layer;
GCL=ganglion cell layer. C-F, ISH with the indicated probes on four mutant and two wild-type backgrounds. Size bar (in C)=100 mm G, Summary of
transcription factors dysregulated in Crx
-/-, Nrl
-/-, and/or Nr2e3
-/- under high stringency criteria. Green arrows indicate activation and red indicate
repression. H and J, ISH with Crx and Prdm1 probes, respectively, on wild-type (CD-1) retinas at the indicated timepoints. J-L, ISH with the indicated
probes on four mutant and two wild-type backgrounds. Note that all ISHs were performed on retinas from 6-9 week old animals with the exception
of those on Crx
-/- which derive from 4-5 week old animals.
doi:10.1371/journal.pone.0000643.g001
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PLoS ONE | www.plosone.org 3 July 2007 | Issue 7 | e643Figure 2. Retinal disease genes in the photoreceptor network. This figure is a manually curated list of all retinal disease genes which are known or
are likely to have a photoreceptor-enriched expression pattern. Those gene symbols which differ between mouse and human are marked with
a single asterisk, and the human equivalents are given here: Cngb1=CNGB1; Gpr98=USH2C; Grk1=RHOK; Gucy2e=GUCY2D; Prom1=PROML1;
Rgs9bp=R9AP; Rp1h=RP1; Ush1g=SANS. ‘Known CRE’ indicates the location of published photoreceptor CREs which have experimental support
(references are given in MATERIALS AND METHODS). Annotations in this column such as ‘6.5 Kb 5’’ means the tested CRE contained the first 6.5 Kb
upstream of the TSS. Known CREs predicted by our algorithm are highlighted in light green. ‘Predicted CRE(s)’ lists candidate CREs predicted by our
algorithm which lie within +/2 15 Kb of the TSS. In some cases, two locations are given which represent that CRE prediction closest to the TSS and
that with the highest score. Only one location is given when they are the same. Experimentally tested CREs are highlighted in red. The CREs tested for
Crx and Elovl4 lie more than 15 Kb downstream of the TSS. The CRE tested for Tulp1 scores below the cutoff threshold of 200. This CRE was selected
for testing during the early phases of this project using an earlier version of PhastCons with which it scored above threshold. A third predicted CRE
location is given for Opn1mw which corresponds to the locus control region. ‘CRE strength’ indicates the estimated strength of the indicated CRE as
tested by electroporation (see Fig. S2). The last four columns of the table show the wild-type-to-mutant ratios of the averaged microarray scores for
the given gene. Dark green=downregulated under high stringency (as described in MATERIALS AND METHODS); light green=downregulated under
low stringency; red=upregulated under high stringency; orange=upregulated under low stringency. A dash indicates that the gene was not
significantly altered in the given mutant. ‘NA’ indicates that this gene is not represented on the Affymetrix Mouse 430 2.0 microarray.
doi:10.1371/journal.pone.0000643.g002
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backgrounds. This finding suggests that the majority of known
human retinal disease genes expressed in photoreceptors is under
the transcriptional control of Crx, Nrl, and/or Nr2e3.
Computational and experimental analysis of
photoreceptor cis-regulatory elements
These microarray and ISH studies identified many of the
important nodes within the photoreceptor TRN. Next we sought
to elucidate the connectivity between these nodes by testing the
hypothesis that the majority of Crx, Nrl, and Nr2e3 target genes are
direct transcriptional targets (i.e., these TFs bind directly to the
CREs of the genes they regulate). Accordingly, a computational
algorithm was developed to identify putative CREs around genes
within the network. The algorithm analyzes the genomic region
15 Kb upstream and downstream of the transcriptional start site
(TSS) of a gene, assigning a score to successive 500 bp stretches of
genomic DNA based on the number, affinity, and clustering of
phylogenetically conserved Crx, Nrl, and Nr2e3 binding sites.
Those 500 bp blocks with a score above a threshold value of 200
are considered likely photoreceptor-specific CREs. This algorithm
was used to make CRE predictions around all genes in the
photoreceptor network (Table S1).
Fig. 3A depicts the output of this algorithm for the Rhodopsin
(Rho) locus. Note that a strong photoreceptor-specific CRE is
predicted within the first 500 bp upstream of the TSS. This peak
corresponds to a previously well characterized photoreceptor-
specific CRE [40,41]. Fig. 3C depicts a retina harvested two weeks
after being electroporated in vivo at P0 with a construct containing
the proximal 2.2 Kb upstream of the bovine Rho gene fused to
DsRed. This promoter, which contains the regulatory peak
predicted by the algorithm, drives very strong, photoreceptor-
specific expression, as shown previously [41]. A literature search
resulted in the identification of 14 genes (out of 58 in the disease
gene list) for which corresponding CREs had been previously
reported (Fig. 2). The algorithm predicts a potential regulatory
peak corresponding to these validated CREs in 79% (11/14) of the
cases (Fig. 2). In addition to the Rho regulatory peak, the successful
predictions include a strong regulatory peak ,3 Kb upstream of
the TSS of Opn1mw, the location of the well characterized locus
control region which drives expression of the X-linked cone opsins
in humans [42]. Furthermore, a prior computational and
experimental analysis of the photoreceptor TRN validated three
novel CREs in vitro (Abca4, Gucy2e, and Rp1h) [43], all of which
were predicted by the algorithm. These findings suggest that the
algorithm has a high sensitivity for identifying active photorecep-
tor-specific CREs around known photoreceptor-enriched genes.
In order to test how reliably the algorithm can predict novel
functional photoreceptor CREs, we assayed the activity of
predicted regulatory peaks around 26 retinal disease genes that
had not been previously studied (Fig. 2). Short PCR products
(range: 0.35 to 1.7 Kb) containing the individual predicted peaks
were tested for enhancer activity by electroporation as CRE-
reporter fusions into retina (Table S9). 73% (19/26) of the
computationally predicted CREs tested drove detectable expres-
sion in photoreceptors (Fig. S2; Table S1). Novel CREs residing
upstream, downstream, and within introns of the genes they
control were identified (Fig. 4). For example, Fig. 4A depicts strong
expression driven by a 1
st intronic CRE from the Rgs9 gene. When
a portion of this same intron not corresponding to a computation-
ally predicted CRE was tested by electroporation, it failed to drive
any expression in the retina (Fig. 4B), thus demonstrating the
specificity of the prediction. The algorithm predicts a regulatory
peak immediately upstream of the TSS of Crx and Nrl, both
regions shown previously to harbor functional CREs [24,44]
(Fig. 4F, G). Furthermore, the algorithm predicts additional peaks
downstream of Crx and within the 3
rd intron and 39 UTR of Nrl.I n
order to test whether these peaks might also contribute to
regulation of these genes, we assayed the peak downstream of
Crx, which drove very strong expression in photoreceptors (Fig. 4F).
The fact that active CREs around the Crx locus contain clustered
Crx sites suggests that they may represent autoregulatory elements,
as noted previously [44]. Alternatively, since Otx2 has a nearly
identical binding preference to that of Crx, some of these sites may
actually be bound by Otx2 in vivo. We also validated a very strong
CRE ,3 Kb upstream of the TSS of Nr2e3 (Fig. 4H). This CRE is
the strongest we have characterized to date. Our analysis has more
than doubled the number of known, experimentally validated
photoreceptor-specific CREs.
In order to classify the novel CREs according to expression
strength, flatmount images of the retinas electroporated with the
novel CRE-reporter constructs were photographed at a defined
exposure time. The images were compared with each other and
with retinas electroporated with two previously characterized
CREs, mouse Rho and Nrl [24,40]. The novel CREs were
categorized into five expression groups (Fig. S2): very strong (4
CREs), strong (6), medium (4), weak (5) and absent (7). Over half
of the CREs which showed activity were classified as either ‘very
strong’ or ‘strong’. By comparison, Rho-CRE was classified as ‘very
strong’ and Nrl-CRE as ‘strong’. Next we examined the CREs
within the five expression classes to determine whether any rules
could be derived to explain their differences in expression level. A
very simple cis-regulatory motif associated with high level
expression in photoreceptors was found. The motif consists of
a single Nrl site less than 40 bp from a Crx site, with individual
and combined affinity scores above defined cutoffs (Fig. S3). When
we assessed all 26 tested photoreceptor CREs for the presence of
this motif, we found that it was present in the following percentage
of CREs: 100% (4/4) of ‘very strong’ CREs, 17% (1/6) of ‘strong’
CREs, 25% (1/4) ‘medium’ CREs, and 0% of ‘weak’ (0/5) and
‘absent’ (0/7) CREs (Fig. S3). This motif is also present within the
first 100 bp of the Rho promoter. These findings suggest that
synergistic activation of photoreceptor gene transcription by Crx
and Nrl as first reported for Rho-CRE [26], is a common principle
of photoreceptor CRE design, at least for CREs which drive high
level expression in rods. The absence of this motif from many
photoreceptor CREs, some with ‘strong’ expression, demonstrates
that clusters of Crx sites (perhaps in combination with sites for
other unidentified TFs) can also support strong photoreceptor-
specific expression.
If the novel photoreceptor CREs identified here represent the
principal regulatory regions controlling expression of the genes in
question, then one might expect there to be a correlation between
the expression strength of a given CRE and the corresponding
gene’s transcript levels in vivo. In order to test this idea, we
compared the expression strength classification of 21 photorecep-
tor CREs (19 novel CREs along with Rho-CRE and Nrl-CRE as
controls) with their mRNA levels (using the average array value of
the gene in question as a surrogate for mRNA levels). We found
that the average wild-type (C57BL/6) array values for genes in
each of the four expression strength categories were as follow: ‘very
strong’=19,607; ‘strong’=15,308; ‘medium’=11,016; and
‘weak’=7,927. This result demonstrates that the average tran-
script levels of genes within a given CRE expression category
correlate with the strength of that category. Despite this trend, the
genes within individual expression strength categories show a wide
range of array values. For example, Rgs9-CRE was rated as
Photoreceptor Gene Network
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low (i.e., ,300). There are a couple possible explanations for this
type of discrepancy. First, although array values roughly correlate
with endogenous transcript levels, they are not a strictly
quantitative measure of mRNA levels. Non-representative array
values could therefore result in a lack of correlation between CRE
strength and endogenous transcript levels. In addition, for
a number of genes (e.g., Crx) there appears to be more than one
functional CRE. In such cases, the endogenous transcript levels
would reflect the concerted activity of all associated CREs and so
would not be expected to correlate perfectly with the activity of
any one CRE tested in isolation. Despite a number of individual
exceptions, the overall correlation between CRE strength and
transcript levels suggests that we have successfully identified the
principal regulatory regions of many of the genes under
consideration.
Figure 3. Computational algorithm to identify photoreceptor cis-regulatory elements. A, Output of computational algorithm for 12 Kb of genomic
DNA around the Rho locus. ‘PhastCons’ indicates the degree of phlyogenetic conservation of a given stretch of DNA as determined by the PhastCons
algorithm. ‘Conserved Crx sites’ indicates the occurrence of a phylogenetically conserved Crx site. The height of the bar representing a site indicates
the ‘affinity’ of the site as measured as the percentile rank of that site’s log odds score relative to the consensus site for that transcription factor=1
(i.e., 100%ile). ‘CRE score’ indicates the likelihood that a given 500 bp stretch (on which the peak is centered) harbors a photoreceptor CRE (details
about scoring are given in MATERIALS AND METHODS). Color code: red if score $500, dark blue if 500.score $200, light blue if score ,200. B,
Pattern of phylogenetic conservation around Rho CRE as displayed by UCSC genome browser. C, Sections of mouse retina electroporated in vivo at P0
with the indicated constructs and harvested at P14. The Rhodopsin promoter used here derives from cow. The white arrows highlight CAG-eGFP-
positive cells in the INL in which DsRed is not expressed. IS=inner segment.
doi:10.1371/journal.pone.0000643.g003
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PLoS ONE | www.plosone.org 6 July 2007 | Issue 7 | e643Figure 4. Novel photoreceptor-specific cis-regulatory elements. A, The top panel shows the output of our computational algorithm for the first
intron of Rgs9. The red bar indicates the region of genomic DNA assayed for CRE activity. The bottom panels show flatmount and cross-sectional
images of a mouse retina electroporated at P0 with the indicated constructs, cultured as an explant, and harvested at P8. The CAG-eGFP is a ‘loading’
control expressed in all retinal cell types. ‘Rgs9-CRE’ consists of the Rgs9 regulatory peak (indicated by the red bar in top panel) fused to DsRed. The
cross-sectional image is a composite of images taken in the green and red channels. Size bar=500 mm for flatmount images and 100 mm for cross-
sections B, A control construct containing the indicated region of DNA from the first intron of Rgs9 which does not correspond to a predicted
regulatory peak. C–E, Additional examples of novel photoreceptor-specific CREs. Note that some annotations of the Rgs9bp locus suggest that the
indicated regulatory peak falls within the 39 UTR of this gene. F–H, CREs around the Crx, Nrl, and Nr2e3 loci. The regulatory peak upstream of the TSS
in F indicates a previously characterized Crx CRE [44]. The Crx-CRE depicted in the bottom panels corresponds to the downstream regulatory peak
identified in the present study (indicated by the red bar). The Nrl-CRE shown in G was previously characterized [24] and is included here as a control.
doi:10.1371/journal.pone.0000643.g004
Photoreceptor Gene Network
PLoS ONE | www.plosone.org 7 July 2007 | Issue 7 | e643In silico evolution of functional photoreceptor
cis-regulatory elements
Comparative analysis of the CREs identified in this study
demonstrated a correlation between a closely linked pair of Crx
and Nrl sites and strong expression in photoreceptors. In order to
test the generality of this association, we created a genetic
algorithm to evolve photoreceptor CREs from random DNA
sequences in silico using a selection filter based on clustering and
affinity of Crx and Nrl binding sites (see MATERIALS AND
METHODS for details). The purpose of this experiment was to
produce sequences that retain the essential features of photore-
ceptor-specific CREs (i.e., closely clustered Crx and Nrl binding
sites), while randomizing all intervening sequences. We found that
in less than 100 generations it was possible to evolve CREs with
features highly reminiscent of naturally occurring photoreceptor-
specific CREs, including some with a strong resemblance to the
well characterized Rho-CRE (compare Fig. 5A with B-D; Table
S10). In order to test whether these in silico evolved CREs could
drive photoreceptor-specific transcription in vivo, we selected three
‘organisms’ from three independent evolutionary runs which had
a distribution of Crx and Nrl binding sites resembling that of Rho-
CRE and which contained the cis-regulatory motif described
above. None of these evolved sequences had significant linear
sequence homology with each other or with Rho-CRE. We then
synthesized these three 400 bp sequences and cloned them
upstream of a minimal basal promoter driving DsRed. This basal
promoter alone does not drive any expression in photoreceptors
(Fig. S2). When electroporated into explanted P0 retinas, these
synthetic CREs drove photoreceptor-specific expression after
several days in culture. All three synthetic CREs were scored as
‘strong’ with syn1-G70 and syn2-G65 being somewhat stronger
than syn3-G55. These results strongly suggest that closely clustered
Crx and Nrl sites are a critical determinant of strong photorecep-
tor-specific expression and that there is significant flexibility in the
architecture of photoreceptor-specific CREs.
We wished to establish with certainty that clustering of Crx and
Nrl sites alone is sufficient to support high-level photoreceptor-
specific expression in these synthetic constructs. However, the
basal promoter used in these experiments contains the proximal
36 bp upstream of the ‘TATA’ box from the bovine Rho locus.
This stretch of DNA includes the so-called ‘Ret4’ element which
consists of a single low-affinity Crx site as well as a binding site for
an unidentified ubiquitous factor [45]. To rule out the possibility
that this ubiquitous factor is playing a significant role in driving
expression in these synthetic constructs, we repeated these
experiments using a basal promoter carrying a mutation known
to eliminate binding of this ubiquitous factor. The expression level
of two constructs (Syn2-G65 and Syn3-G500) were basically
unchanged and the levels of two others (Syn1-G70 and Syn3-G55)
Figure 5. In silico evolution of functional photoreceptor cis-regulatory elements. A, Flatmount and cross-sectional images of mouse Rho-CRE fused
to DsRed co-electroporated with CAG-eGFP. All constructs were electroporated at P0, cultured as explants, and harvested at P8. The column labeled
‘CRE architecture’ shows the distribution of Crx (top half) and Nrl (bottom half) sites with the indicated ‘affinity’ as described in the legend at the top
of the figure. The orientation of a given site is indicated by the direction of the triangle representing that site. The score on the y-axis is the log odds
score for that site which reflects its closeness to consensus. Size bar=500 mm for flatmount images and 100 mm for cross-sections B-D, Images of
retinas electroporated with the indicated synthetic CREs. For example, ‘Syn1-G70’ indicates a sequence corresponding to the genome of the ‘fittest’
organism of generation 70 in evolutionary run 1. The CREs in B-D derive from three separate evolutionary runs. E, Graph of first 700 generations of
evolutionary run 3. The four ‘organisms’ from this run whose genomes were tested for CRE activity are circled and images of their expression patterns
are given in Fig. S4. F, Graph of expression strength of four synthetic CREs from evolutionary run 3.
doi:10.1371/journal.pone.0000643.g005
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suggest that clusters of Crx and Nrl sites alone are sufficient to
drive high-level expression in photoreceptors in this assay system.
In order to determine whether further evolution could be used
to generate CREs with progressively stronger expression, CRE-
reporter constructs corresponding to the fittest organism from the
150
th, 300
th, and 500
th generations of run number 3 (the same run
from which syn3-G55 was derived) were synthesized. The 500
th
generation construct drove very strong expression in photorecep-
tors, comparable to some of the strongest naturally occurring
CREs we examined (Fig. S4D). In addition, we found that
expression was detectable at progressively earlier timepoints the
more highly evolved the element (See Fig. 5E, F; Fig. S4).
However, there was not a clear linear progression in the ultimate
strength of expression. In fact, the CRE from generation 150 was
significantly weaker than that from generation 55 (Fig. S4). The
reason for this decrease is unclear but could relate to the
acquisition of a binding site for an unidentified repressor.
DISCUSSION
We have employed experimental and computational analyses of Crx,
Nrl,a n dNr2e3 mutant retinas to define a comprehensive model of
the mouse photoreceptor TRN which contains over 600 genes. This
model will serve as a template for understanding retinal diseases at
a systems level. Using computational prediction and in vivo validation
we were able to identify 19 new photoreceptor-specific CREs, thus
doubling the number of known photoreceptor-specific CREs. Given
recent progress in using viral vectors for intraretinal gene therapy in
animal models of blindness [46,47], these novel CREs could prove
useful as gene-specific drivers for rescue constructs in human gene
therapy. This study also demonstrates the usefulness of electropora-
tion into living tissue as a means of assaying mammalian CREs in
a rapid manner which circumvents costly mouse transgenesis. We
believe that this approach can be extended to other cell types and
organs and can easily be made quantitative.
Our microarray and in situ hybridization results showed that
many photoreceptor genes appear to be co-regulated by Crx and
Nrl, a finding which is corroborated by prior analyses of individual
photoreceptor-specific CREs [26,27]. At the same time, we also
showed that maintenance of normal Nrl transcript levels depends
on Crx. This latter result suggests that the similarities between the
sets of target genes regulated by Crx and Nrl could, in part, be
attributable to the decrease in Nrl expression in Crx
-/-. Although
we cannot completely rule out this possibility, multiple lines of
evidence suggest that, for many co-regulated genes, Crx’s
transcriptional control is independent of Nrl. First, several cone-
enriched genes (e.g., Opn1sw, Pde6h, and Arr3) are downregulated
in Crx
-/- and upregulated in Nrl
-/- (see Table S1). This pattern is
the opposite of what one would expect if Crx’s regulation of these
genes was exclusively mediated via maintenance of Nrl transcrip-
tion. Secondly, we showed that Crx binding sites are abundant
within many functional CREs around co-regulated photoreceptor
genes. Again, this finding would not be expected if Crx’s control of
these genes was mediated solely via downstream activation of Nrl.
Despite these points, the extent to which the transcriptional
changes seen in Crx
-/- are due to a decrease in the levels of Nrl is
an important problem for future studies.
Using synthetic CREs, we found that clusters of Crx and Nrl
binding sites alone are sufficient to drive strong photoreceptor-
specific expression in the mouse retina. This finding was somewhat
surprising given the proposed role of other photoreceptor TFs in
the regulation of rod photoreceptor gene expression. For example,
recent studies have shown that mice carrying mutations in the
nuclear receptor TF, Nr2e3, show a delay in the onset of Rho
expression [20] and modest decreases in the levels of expression of
several other rod genes [19]. In addition, Neurod1 is thought to
regulate gene expression in rods since mice carrying mutations in
this TF show rod degeneration [30]. Furthermore, we demon-
strated in this study that there is a small subset of photoreceptor
genes whose expression is unchanged in Crx
-/-;Nrl
-/- (see Fig. S1),
suggesting that there must be alternative activators of rod gene
expression. In general, however, the effects of Nr2e3 and Neurod1
mutations on rod gene expression are modest [18-20] (and data
not shown). We therefore propose that Crx and Nrl are the
primary activators of gene expression for the majority of rod genes
in the mouse, and that other TFs expressed in rods such as Nr2e3
and Neurod1 are involved in fine-tuning expression.
In analyzing the novel photoreceptor CREs identified in the
present study, we were able to define a simple cis-regulatory motif
associated with high-level expression in photoreceptors which
consisted of a pair of Crx and Nrl binding sites. This motif is
reminiscent of a cis-regulatory motif recently identified in the
regulatory regions of Drosophila immune response genes which
consists of a heterotypic pair of REL and GATA binding sites with
a defined orientation relative to each other [48]. The mammalian
eye offers other intriguing examples of cell types in which two
different TFs play the predominant role in regulation of gene
expression. For instance, Otx2 and MITF are known to be the
principal TFs involved in regulation of retinal pigment epithelium
(RPE) gene expression and are thought to act at the same
hierarchical level in the RPE gene network [49]. In addition, gene
expression in the mammalian lens is known to depend crucially on
binding sites for two types of TF, Maf and Sox [50]. In this case,
multiple members of the Sox family are known to participate in
different stages of lens differentiation [51], but they all share a very
similar binding site. These findings suggest that such ‘two-site’
motifs may be a common feature of metazoan cis-regulatory
regions. We propose that despite the apparent diversity of TFs
expressed in a given cell type (e.g., Fig. 1G) in many cases only two
or three TFs may play the major role in control of gene expression.
The host of other TFs in that cell type may either be involved in
fine-tuning gene expression or in regulating the expression of
a selected subset of genes.
Another example of this general principle is the control of cone
photoreceptor gene expression in the mouse. Many cone genes are
activated by Crx and many are repressed (in rods) by Nrl and Nr2e3
[12,13,18–20,25]. These three TFs therefore appear to be the
primary regulators of cone gene expression. However, several
other cone TFs have been shown to regulate a small subset of cone
genes. For example, Thrb2 is known to be required for activation
of Opn1mw and dorsal repression of Opn1sw in the mouse [52]. The
TF, Rxrg, appears to have an even more specialized role in cone
photoreceptors in that it is involved in the dorsal repression of
Opn1sw, but does not appear to regulate Opn1mw [29]. Lastly,
a recent paper showed that the orphan nuclear receptor TF,
RORbeta, is required for the activation of Opn1sw [53]. Although
it is possible that these three TFs have other transcriptional targets
in cone photoreceptors, it may also be the case that they their
transcriptional regulatory role is restricted to only a subset of genes
in this cell type.
A recent study identified functional CREs in the human genome
by searching for contiguous blocks of extreme phylogenetic
conservation and then testing them in transgenic mice [4]. We
compared the location of the 19 novel photoreceptor CREs
identified here with a set of over 3000 elements conserved between
human and Fugu identified in that study. We found that none of
the 19 CREs were included in that set (data not shown). This result
suggests that approaches which rely solely on identifying extended
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many cell-type specific CREs. The algorithm used in the present
study only requires that the identified binding site itself be
phylogenetically conserved. This approach was employed because
examination of known photoreceptor CREs demonstrated that, in
many cases, blocks of conservation were found to encompass only
a single binding site (e.g., the rightmost Crx site in Fig. 3B).
Given the reliance of the CRE-finding algorithm used in the
present study on clustering of phylogenetically conserved Crx
binding sites which contain the canonical ‘TAAT’ sequence bound
by many homeodomain TFs, putative regulatory peaks predicted
around non-photoreceptor genes must be interpreted with caution.
A preliminary analysis of the genomic regions around 20,000
mouse genes using this algorithm detected a marked enrichment of
predicted regulatory peaks around TFs and other developmental
regulators (data not shown). Nearly half of the 100 top-ranked
genes in this analysis were homeodomain TFs, most of which are
unlikely to be involved in photoreceptor development and
therefore represent false positives. We believe there are two
possible explanations for this result. First, the scoring algorithm is
not normalized according to the extent of regional phylogenetic
conservation of non-coding DNA. Since developmental regulators
including TFs are known to exhibit a greater degree of phylo-
genetic conservation in their surrounding non-coding regions [54],
the algorithm would be expected to predict more regulatory peaks
in such regions by chance alone. Secondly, the abundance of
homeodomain TFs among the top-ranked genes suggests that the
algorithm may be identifying bona fide CREs containing clusters
of binding sites for homeodomain TFs other than Crx. Given these
caveats, the algorithm presented here identifies functional CREs
with considerable reliability when applied to the genomic region
around photoreceptor-enriched genes.
MATERIALS AND METHODS
Oligonucleotide microarray analysis
Microarray analysis of P21 Crx
-/- and Crx
-/-;Nrl
-/- retinas was
performed on Affymetrix mouse genome 430 2.0 GeneChip arrays
(Affymetrix, Santa Clara, California, United States). The full
microarray datasets for the Crx
-/- and Crx
-/-;Nrl
-/- analyses are
given in Tables S5 and S6. A comparison of these microarray
datasets alongside the results of our prior microarray studies of
Nr2e3
-/- and Nrl
-/- are presented in Table S4. A total of three
microarray hybridizations were performed for each mutant. Since
the Crx mutant allele is on a 129 background, we also performed
three control microarray hybridizations with retinas derived from
129S6/SvEv mice at P21. For each microarray, RNA was
prepared from 4-6 freshly dissected retinas derived from 2-3
animals at P21. Probes were synthesized starting with 10 mgo f
total RNA for each sample according to manufacturer’s instruc-
tions (Affymetrix). Hybridization, washing, and scanning of the
microarrays were all performed at the Bauer Center for Genomics
Research at Harvard University according to manufacturer’s
instructions (Affymetrix).
Initial data analysis was carried out using the GeneChip
Operating System (GCOS) software from Affymetrix. Pairwise
comparisons were made between individual mutant microarray
results and controls. For our ‘low stringency’ analysis, up- and
downregulated genes were determined by using Wilcoxon’s signed
rank test to compare mutant and control microarrays in a pairwise
fashion with a p-value=0.002. Only those array features which
were significantly ‘increased’ or ‘decreased’ in three out of three
microarray comparisons were considered to have met our criteria
for inclusion in the low stringency datasets.
To create a ‘high stringency’ dataset, we used the same
approach used previously for the Nrl mutant [25]. First, we
separated the features in the low stringency datasets into three
expression level categories: (for analysis of downregulated features)
(1) features whose average microarray score in the wild-type
retina (score129)i s$5000; (2) 1000#score129,5000; and (3)
100#score129,1000. For analysis of upregulated features, the
same categories were created using the average microarray score
for the mutant. Next, we sorted each of these three sub-lists
according to the ratio of their average wild-type to average mutant
scores and retained only those features that passed the following
thresholds for the three expression categories: category (1) at least
a 2-fold change; category (2) at least a three-fold change and
category (3) at least a 5-fold change. In this manner, we applied
progressively more stringent fold-change requirements for the
features showing lower levels of expression. Next, in order to
create a non-redundant list of up- and downregulated genes (since
our initial feature lists contained multiple Affymetrix features
which correspond to a single gene) we used the DAVID functional
annotation tool (http://david.abcc.ncifcrf.gov/) to annotate the
low and high stringency lists. We then wrote a Perl script to sort
and format the DAVID outputs (script available on request). Data
from our previously published microarray study of the Nr2e3
mutant [20] were processed in the same way to generate high and
low stringency datasets. High stringency datasets for the Nrl
mutant were reported previously [25], and low stringency datasets
for the Nrl mutant were obtained as described above.
Since the Crx and Nrl mutant alleles are on different back-
grounds (129 and B6, respectively), the Crx;Nrl double mutant
created in the present study was on a mixed 129 X B6
background. Since microarray data from a mixed wild-type
background were not available as a control, it was necessary to use
the pure 129 and B6 wild-type datasets as controls for the Crx;Nrl
double mutant. Accordingly, pairwise comparisons were made
between individual Crx
-/-;Nrl
-/- microarray results and both 129
and B6 controls using the GeneChip Operating System (GCOS)
software from Affymetrix (i.e., a total of six pairwise comparisons).
For our ‘low stringency’ analysis, up- and downregulated genes
were determined as described above for the single mutants with
the exception that we required that a given feature be up- or
downregulated in all six pairwise comparisons in order to be
included in our low stringency dataset. High stringency datasets
for Crx
-/-;Nrl
-/- were then obtained in the same manner as
described for the single mutants.
RNA in situ hybridization
ISH on tissue sections was performed essentially as described
previously [55]. Most of the ISH images of Nrl
-/- and B6 were
published previously [25] with the exception of the images for
Esrrb, Otx2 and Neurod1. ISH images of Nr2e3
-/- using a subset of
the probes employed in the present study were also published
previously [20] but on sections from earlier developmental
timepoints (P14 and P28). Briefly, retinas from 6-9 week old
Nr2e3
-/-, Nrl
-/- , Crx
-/-;Nrl
-/-, C57BL/6 and 129S6/SvEv mice and
from 4-5 week old Crx
-/- mice were harvested in PBS and
immediately put in 4% paraformaldehyde fixative at 4 ˚C overnight.
The earlier timepoint was used for Crx
-/- because of more rapid
onset of degeneration in this mutant. Tissue was equilibrated in
30% sucrose/PBS and then embedded in OCT (Tissue Tek).
Sectioned tissue from all four mutants and both wild-type controls
were placed on a single glass slide which was then hybridized with
RNA riboprobes synthesized from PCR products derived from the
templates described in our prior study [25] with the exception of
probes for Esrrb, Otx2 and Neurod1. The latter probes were derived
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and an in-house clone corresponding to nucleotides 966-1845 of
NM_010894 (Neurod1).
Photoreceptor cis-regulatory element scoring
algorithm
Position frequency matrices (PFMs) were constructed for Crx, Nrl,
and Nr2e3 based on previous literature [10,18,56]. Given that all
members of the maf subfamily of leucine zipper TFs (which
includes Nrl) have very similar DNA binding preferences [57],
a well characterized PFM for v-maf [56] was used as the ‘Nrl’
PFM. Nrl and other maf subfamily members can bind to 13-bp
and 14-bp variants of their binding site which differ by one
nucleotide in the middle of the motif. In preliminary computa-
tional analyses we found very few instances of the 14-bp motif
around photoreceptor genes (data not shown) and we therefore
only used the 13-bp motif in all subsequent analyses. PFMs were
converted to position weight matrices (PWMs) using the following
formula:
log2
n(b,i)z
ﬃﬃﬃ
N
p
4
Nz
ﬃﬃﬃﬃﬃ
N
p
p(b)
where n(b, i) is the number of occurrences of base b at position i, N
is the number of sequences used to create the PFM, and p(b) is the
background genomic frequency of base b (given a GC content of
0.43 in the mouse). Site scoring was then performed on the NCBI
Mouse Build 36 using the TFBS Perl module [58]. PhastCons
release mm8 was used to estimate the degree of conservation for
each binding site [59]. Average PhastCons scores for each binding
site were calculated and then the binding site scores were weighted
according to the formula:
w(i)~0:8:rLOSz0:2:pave
Where w(i) is the weighted binding site score, rLOS is the raw log
odds score for the site and pave is the average PhastCons score for
the site. This weighting ensures that binding sites that lie within
phylogenetically conserved stretches of the genome contribute
a higher score to the overall score of that 500 bp window. CREs
typically consist of closely linked clusters of binding sites for
multiple TFs [1,2]. Accordingly, closely clustered phylogenetically
conserved binding sites were given more weight than sites that
were less closely clustered. Our scoring scheme computed module
scores for 500 bp windows according to the following formula:
S~
X
i
(1zn75(i)z2:m75(i)):w(i):f(w(i))
where S is the score for the 500 bp window. The summation is
done for all binding sites in the window with i being the iteration
index, n75 is the number of homotypic neighbors (i.e., Crx-Crx,
Nrl-Nrl, or Nr2e3-Nr2e3 pairs) within 675 bp, m75 is the number
of heterotypic neighbors (i.e., Crx-Nrl pairs etc.) within 675 bp,
w(i) is the weighted binding score, and f(w(i)) is defined to be 4 if
w(i) is greater than 90% of the maximum log odds score for that
particular PWM. This scoring scheme gives greater weight to high
affinity sites (i.e., sites whose log odds scores are in the top 10% of
all sites for that TF) and closely clustered (i.e., within 75 bp of each
other) heterotypic pairs of sites. Once a given 500 bp window is
scored, the window is shifted by 100 bp and the process is
repeated. CRE predictions were made for a 615 Kb interval
around genes in our dataset. Gene structure information was
accessed using the EnsEMBL Perl modules (version 40) [60]. The
BioPerl Graphics package [61] was used to visualize predictions
superimposed on gene structures. The script for this algorithm is
available from the authors on request.
Literature analysis of previously characterized
photoreceptor cis-regulatory elements
Through a literature search we identified a total of 14 retinal
disease genes for which mammalian CREs had been previously
experimentally analyzed: Abca4, Crx, Gnat1, Gnat2, Grk1, Gucy2e,
Nrl, Opn1mw, Opn1sw, Pde6a, Pde6b, Rho, Rp1h, and Sag [24,27,41–
44,62–67].
Construction of cis-regulatory element fluorescent
reporters
PCR primers were designed around computationally predicted
CREs using Primer3 [68]. The sequences of all PCR primers used
(along with restriction sites added for purposes of subcloning) are
given in Table S9. Two different starting vectors were used for the
construction of the CRE-DsRed reporters: Rho-basal and no-basal.
The Rho-basal vector was used for all CRE that resided at some
distance for the gene’s endogenous basal promoter region. The no-
basal vector was used for those CRE that occurred immediately
upstream of the TSS. In the latter case, the gene’s own
endogenous basal promoter could be cloned directly upstream of
the DsRed coding sequence. The Rho-basal vector was created by
replacing the 2.2 Kb bovine Rho promoter region in pRho-2.2K-
DsRed [69] with a minimal basal promoter which contains
nucleotides -36 to +79 around the ‘TATA’ box of bovine Rho. This
Rho minimal basal promoter includes the so-called ‘Ret4’ element
which contains a single low affinity Crx site (log odds score=5.1)
and a binding site for an unidentified ubiquitous factor [45]. The
following PCR primers were used to create this minimal basal
promoter: 59- taccgCTCGAGatatctctagaggtaccgaattcgattcagccgg-
gagcttag and 59- tccgaaCCCGGGgatgcttct. The 59 primer
includes an XhoI site for cloning (in upper case) and the following
additional enzyme sites for subsequent subcloning of CREs into
the Rho-basal vector (from 59 to 39): EcoRV, XbaI, KpnI, and EcoRI.
The downstream primer contains a SmaI site (in upper case) for
cloning. This Rho basal promoter PCR product was digested with
XhoI and SmaI and ligated into the pRho-2.2K-DsRed vector that
had been previously digested with SalI and SmaI, treated with calf
intestinal alkaline phosphatase (AP), and separated from the 2.2
Kb bovine Rho promoter fragment by gel electrophoresis. The Rho-
basal vector was the product of this ligation. The no-basal vector
was created by digesting pRho-2.2K-DsRed with SalI, treating the
cut vector with AP, and ligating in a short linker created by
kinasing and annealing the following two oligonucleotides: 59-
tcgacgatatctctagagaattcc and 59-tcgaggaattctctagagatatcg. The
CAG-eGFP vector used as a loading control for all electropora-
tions was described previously (referred to in that paper as pCAG-
GFP) [69].
A total of six 400 bp synthetic CREs (Syn1-G70, Syn2-G65,
Syn3-G55, Syn4-G150, Syn3-G300, and Syn3-G500) were
synthesized (Integrated DNA Technologies Inc.) with appropriate
restriction enzyme sites added to the ends for purposes of
subcloning into Rho-basal.
Retinal electroporation and explant culture
In vivo and in vitro electroporation and explant culture were
performed as described previously [69] with the following
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dissected in serum free medium (SFM; 1:1 DMEM:Ham’s F12
(Gibco), 100 units/ml penicillin, 100 mg/ml streptomycin, 2 mM
L-glutamine (Gibco) and 2 mg/ml insulin (Sigma)) from surround-
ing sclera and soft tissue leaving the lens in place. Retinas were
then transferred with forceps to an electroporation chamber
containing a 1 mg/ml solution of supercoiled DNA in PBS (model
BTX453 Microslide chamber, Genetronics Inc.). The chamber
had been previously divided with silicon cement into four sub-
chambers each with a volume of ,60 ml. Next, five square pulses
(30 V) of 50-ms duration with 950-ms intervals were applied using
a pulse generator (model ECM 830, Genetronics Inc.). Electro-
porated retinas were removed from the electroporation chamber
and allowed to recover in SFM for several minutes before being
transferred to the same medium supplemented with 5% fetal calf
serum (Gibco) for several minutes. The retinas were then placed
(lens side down) on polycarbonate filters (Whatman, 0.2 mm pore
size) and cultured at 37uC in SFM supplemented with 5% fetal calf
serum for 8 days. Upon harvesting, retinas were fixed in 4%
paraformadehyde in PBS for 30 minutes washed two times with
PBS. Next, the retinas were flat-mounted (photoreceptor side up)
and examined using a BX51 compound microscope (Olympus).
Digitalimages were capturedusing a DP70camera(Olympus).After
imaging of flatmounts, retinas were equilibrated in 30% sucrose/
PBS overnight at 4uC and embedded in OCT. 16 mmc r y o s e c t i o n s
were collected, and confocal micrographs were captured using
a BX61WI microscope (Olympus) equipped with a DSU spinning
disc and an ORCA-ER CCD camera (Hamamatsu).
The expression strength of the novel CREs were categorized in
the following manner. Images of the best electroporated retina for
each CRE-reporter construct (defined as that retina with the
greatest area and intensity of green fluorescence of the retinas
examined for a given construct) were captured in both green and
red channels at the same exposure time (1/300 second) for all
constructs. These images were then compared side-by-side with
images for all other constructs as well as images of retinas
electroporated with Rho-CRE and Nrl-CRE controls. ‘very strong’
expression was defined as red fluorescence (i.e., expression levels of
DsRed driven by the CRE in question) that showed extensive pixel
saturation (i.e., yellow areas on the image) at 1/300 second
exposure. ‘strong’ expression was defined as widespread robust red
fluorescence without significant saturation. ‘medium’ expression
was defined as red flourescence that was visible at 1/300 exposure
but that was considerably weaker or more patchy than that seen in
‘strong’ constructs. ‘weak’ expression was defined as any definite
expression in photoreceptors that was not easily visible in a 1/300
second exposure. ‘absent’ expression was defined as absolutely no
detectable expression in the retina.
Algorithm for in silico evolution of photoreceptor
cis-regulatory elements
A genetic algorithm was developed in Matlab to evolve
photoreceptor-specific CREs in silico. The original inspiration for
this algorithm came from a paper by Thomas Schneider [70]. The
algorithm consists of four distinct steps: initiation, mutation,
selection, and reproduction. In the initiation step, random 400 bp
DNA sequences were generated in accordance with the GC
content of the mouse genome (0.43), and a single such sequence
lacking Crx and Nrl sites (i.e., containing no Crx or Nrl sites with
log odds scores greater than 4 and 6, respectively) was selected.
This sequence was then assigned to 100 ‘organisms’, each
consisting of a single 400 bp genome. In the mutation step,
random point mutations were assigned to individual organisms
according to a Poisson distribution such that, on average, each
organism received one point mutation per generation.
In the selection step, the ‘fitness’ of each organism was
determined by assessing the affinity of any Crx or Nrl sites in
the organism’s genome (scored using the PWMs and TFBS Perl
module described above), the spacing between pairs of sites,
whether the pairs of sites were homotypic (i.e., Crx-Crx or Nrl-Nrl)
or heterotypic (i.e., Crx-Nrl) and the distance of sites from the
TSS. Specifically, the fitness score, S, for each 400 bp organism
was calculated using the following formula:
S~
X
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where rLOS is the raw log odds score of the site being scored; y is
a normalizing factor to even the contribution made by Crx and
Nrl sites, where y=3 for Crx sites and 2.5 for Nrl sites (the raw log
odds score for a high affinity Nrl site is greater than that for a high
affinity Crx site since the Nrl binding site is almost twice as long); i
represents all other Crx or Nrl binding sites within the 400 bp
genome; fpair is a weighting term which equals 2 for homotypic
neighboring sites (i.e., Crx neighbors if site being scored is Crx; Nrl
neighbors if site being scored is Nrl) and 8 for heterotypic
neighboring sites (i.e., greater weight is attributed to Crx-Nrl pairs
to reflect the cis-regulatory motif defined in this study); gdist is
a second weighting term which reflects the importance of site
clustering: gdist=0ifi.100 bp from the site being scored; gdist=1if
40 bp,i#100 bp; and gdist=2ifi#40 bp (this weighting term also
reflects the important contribution of sites within 40 bp of each
other as demonstrated in our cis-regulatory motif); lastly, hTSS is
a weighting term which increases from 1 to 4 the closer the
location of the site being scored is to the 39 end of the 400 bp
genome (this term is intended to reflect the importance of
proximity of binding sites to the TSS; several of the most strongly
expressing endogenous CREs examined (e.g., Rho, Kcnv2, and
Nr2e3) have key TF binding sites less than 200 bp from the TSS.
For purposes of scoring, Crx and Nrl sites with log odds scores less
than 6 and 9, respectively, were ignored.
After assignment of a fitness score, the organisms are ranked
from highest to lowest fitness, the bottom 50 organisms are culled,
and the top 50 are permitted to differentially reproduce to restore
the original population of 100. In this reproduction step, the top
ten scoring organisms each contribute three identical offspring to
the next generation, the 21
st to 40
th highest scoring organisms
contribute two identical offspring to the next generation, and the
41
st to 50
th highest scoring organisms each contribute one offspring
to the next generation. The new population of 100 organisms
reenters the algorithm at the mutation step and the cycle is
repeated. The script for this algorithm is available from the
authors on request.
The full datasets for the three evolutionary runs used in this
study are given in Table S10.
Graphing of cis-regulatory element architecture
A Matlab graphic user interface (GUI) was developed to visualize
the spatial arrangement of Crx and Nrl sites on a segment of DNA.
For color-coding of Crx and Nrl binding sites the following log
odds score thresholds were used: 5,CrxLOS,7 (yellow);
7#CrxLOS,9 (orange); CrxLOS#9 (red); 9,NrlLOS,12 (light
blue); 12#NrlLOS,15 (blue); NrlLOS#15 (dark blue). The term
‘affinity’ used in this paper to describe individual Crx and Nrl sites
is not actually the true affinity of the binding sites in question but
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that of the consensus site for that TF as derived from the PFMs.
SUPPORTING INFORMATION
Figure S1 In situ hybridizations for genes not in Table S1. ISH
images on four mutant and two wild-type backgrounds for nine
photoreceptor-enriched genes which were not dysregulated in
Crx
-/-, Nrl
-/-,o rNr2e3
-/- and therefore not included in Table S1.
Size bar=100 mm.
Found at: doi:10.1371/journal.pone.0000643.s001 (7.10 MB TIF)
Figure S2 Expression strength categorization of novel photore-
ceptor cis-regulatory elements. Images of retinas electroporated
with the indicated constructs at P0, cultured as explants, and
harvested at P8. All 26 predicted CREs tested in the present study
are shown in flatmount along with previously characterized mouse
Rho-CRE and Nrl-CRE as controls. Also shown are retinas
electroporated with the ‘vector only’ controls: ‘Rho-basal’ and
‘No-basal’ (described in METHODS). For comparison purposes,
all images were taken at the same exposure time (1/300 second)
except Nr2e3-CRE (1/600 second) and all CREs categorized as
‘absent’ (1/150 second). The ‘vector only’ controls were also taken
at (1/150 second). Images taken with longer exposures to highlight
expression of ‘weak’ CREs are given in Table S1. Some of the
retinas electroporated with constructs with ‘absent’ expression
show faint, diffuse red fluorescence which represents autofluores-
cence in the lens. Size bar=100 mm.
Found at: doi:10.1371/journal.pone.0000643.s002 (9.61 MB TIF)
Figure S3 Cis-regulatory motif associated with high-level
expression in photoreceptors. A-D, Images showing the distribu-
tion of Crx and Nrl sites (as described in Legend at the top of the
figure) in four ‘very strong’ CREs. All four CREs show a simple
cis-regulatory motif (summarized in E) which is boxed. E,
Summary of novel cis-regulatory motif associated with high-level
expression in photoreceptors. ‘Crx
LOS’ indicates the log odds
score for the Crx site, a measure of its closeness to consensus. In
addition to minimal log odds scores for the individual Crx and Nrl
sites, this grammar rule requires that their combined log odds
scores be $ 16.0 as indicated and that the two sites be ,40 bp
apart. F, Summary of percentage of novel CREs from each
expression strength category which contain the cis-regulatory
motif described in E.
Found at: doi:10.1371/journal.pone.0000643.s003 (7.33 MB TIF)
Figure S4 Expression of synthetic constructs from evolutionary
run 3. A-D, Images of retinas electroporated with the indicated
constructs at P0, cultured as explants, and harvested at P8. Syn3-
G55 is shown in Fig. 5 and is reproduced here for comparison. All
four constructs derive from the ‘organisms’ indicated in Fig. 5E.
The expression strengths of these four constructs over time are
summarized in Fig. 5F. Details about ‘CRE architecture’ notation
are given in Fig. 5. Size bar=500 mm for flatmount images and
100 mm for cross-sections.
Found at: doi:10.1371/journal.pone.0000643.s004 (6.18 MB TIF)
Table S1 Genes in the mouse photoreceptor transcription
network. This table is a database which includes all genes
dysregulated in Crx
-/-, Nrl
-/-, and/or Nr2e3
-/- under high
stringency criteria. Each row in the database represents a gene
in the network and includes multiple links to additional types of
information about that gene. ‘Large image gene +/2 15 Kb’ links
to an image of our computational prediction of photoreceptor
CREs in the genomic region 15 Kb upstream and downstream of
the gene in question. ‘Closeup image TSS +/2 15 Kb’ links to an
image of our computational prediction in the region 15 Kb on
either side of the gene’s TSS. Black bars within this image
highlight the following regulatory peaks (if any are present): the
peak closest to the TSS and the peak with the highest CRE score
within this 30 Kb window. For those genes whose CRE
predictions were tested experimentally, a red bar in this image
indicates the location of the CRE that was tested. For Crx and
Elovl4 the tested CRE is outside of this 30 Kb window and is
therefore indicated in the ‘Large image’. ‘Links’ contains links to
the UCSC genome browser, ENSEMBL, and NCBI database
entries for the indicated gene, if available. ‘Max score (threshold of
200)’ contains the score of the highest predicted regulatory peak
within the 30 Kb window around the gene’s TSS. If this window
does not contain any predicted peaks $ 200 (our cutoff threshold)
no value is given (indicated by a dash). The next four columns of
the table (‘Nr2e3-/-’ etc.) show the wild-type-to-mutant ratios of
the averaged microarray scores for the given gene. For those genes
to which more than one Affy tag correspond, the data for the first
one listed under ‘Affy Mouse 430 2.0’ is given. Dark green=-
downregulated under high stringency (as described in METH-
ODS); light green=downregulated under low stringency; red=u-
pregulated under high stringency; orange=upregulated under low
stringency. A dash indicates that the gene was not significantly
altered in the given mutant. ‘NA’ indicates that the gene is not
represented on the Affymetrix Mouse 430 2.0 microarray. ‘In situ
hybridization’ links to ISH images of the gene, if available.
Alterations in expression level # 2-fold on microarray are
generally not detectable by ISH. ‘Electroporation’ links to images
of retinas electroporated with the CRE indicated by the red bar in
‘Closeup image TSS +/2 15 Kb’, if available. All images were
taken at the same exposure time (1/300 second) unless indicated in
the image. ‘Averaged Affy scores’ includes the average score for
the first Affy tag listed under ‘Affy Mouse 430 2.0’ from three
independent microarray experiments in the given mutant or wild-
type background. Each mutant is shown in association with the
score for its respective wild-type background. The score for the
‘B6;129’ control for ‘Crx
-/-, Nrl
-/-’ is the average of the averaged B6
and 129 scores (as described in more detail in METHODS).
‘Locus’ indicates the chromosomal locus of the gene. ‘Affy Mouse
430 2.0’ contains all Affy tags corresponding to the gene in
question which were dysregulated under high stringency criteria in
any of the single mutants. An interactive version of this table is
available at: http://www.plosone.org/suppinfo/pone.0000643/
Found at: doi:10.1371/journal.pone.0000643.s005 (27.90 MB
ZIP)
Table S2 Genes dysregulated in Nr2e3
-/-, Crx
-/-, Nrl
-/-, and
Crx
-/-; Nrl
-/- under high stringency criteria. This list contains eight
sub-lists of genes which met high stringency criteria for up- or
downregulation in Nr2e3
-/-, Crx
-/-, Nrl
-/-, and Crx
-/-; Nrl
-/- retinas
(described in METHODS). The data for Nrl
-/- were published
previously [25] and are reproduced here for convenience. The
microarray datasets for Nr2e3
-/- were also published previously
[20], but this analysis is new. Each sub-list is subdivided into three
parts by color coding (taking Nrl-downregulated genes as an
example): light green: genes whose average raw microarray score
in the given mutant retina (score
Nrl)i s$5000; brown :
1000#score
Nrl,5000; and pink: 100#score
Nrl,1000. "Nrl_ave"
and "B6_ave" indicate the average scores for Nrl mutant and wild-
type (C57BL/6) obtained for the indicated feature from three
separate microarray experiments. Within each of the three sub-
lists, genes are listed in order of their degree of change in the Nrl
mutant retina (relative to wild-type) as indicated by the ratio of
their average wt: Nrl ratios ("B6_ave/Nrl_ave"). The columns
labeled "Additional Affy_IDs" contain additional Affymetrix
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question and which were also met our stringent criteria for
upregulation in the Nrl mutant.
Found at: doi:10.1371/journal.pone.0000643.s006 (0.43 MB
XLS)
Table S3 Genes dysregulated in Nr2e3
-/-, Crx
-/-, Nrl
-/-, and
Crx
-/-; Nrl
-/- under low stringency criteria. This list contains eight
sub-lists of genes which met low stringency criteria for up- or
downregulation in Nr2e3
-/-, Crx
-/-, Nrl
-/-, and Crx
-/-; Nrl
-/- retinas
(described in METHODS). The data for Nrl
-/- and Nr2e3
-/- were
published previously [20,25], but this analysis is new and they are
therefore included here for completeness. Each row corresponds to
a single gene which is dysregulated in the given background.
‘Affy_ID’ is an Affymetrix feature identifier representative of the
given gene. Taking ‘Nr2e3-downregulated genes as an example,
‘Nr2e3_ave’ and ‘B6_ave’ columns show average Affymetrix
scores for the feature in the first column from three independent
microarray experiments. ‘B6_ave/Nr2e3_ave’ is the ratio of the
B6 to Nr2e3
-/- ratios. Within each sub-list, genes are listed in order
of their degree of change in the mutant retina (relative to wild-
type) as indicated by the ratio of their average wild type-to-mutant
ratios. ‘Additional Affy_IDs’ show additional Affymetrix tags
which correspond to the gene question in those cases where there
is more than one.
Found at: doi:10.1371/journal.pone.0000643.s007 (2.19 MB
XLS)
Table S4 Complete averaged microarray datasets for Nr2e3
-/-,
Crx
-/-, Nrl
-/-, and Crx
-/-; Nrl
-/-. This table contains average scores
for all four mutants compared to their respective wild-types for all
45,037 Affymetrix feature identifiers. The data for Nrl
-/- and
Nr2e3
-/- were presented previously [20,25] and are reproduced
here for comparison. The descriptors for the columns are as
described in Table S3.
Found at: doi:10.1371/journal.pone.0000643.s008 (18.01 MB
XLS)
Table S5 Complete microarray datasets for wild-type vs. Crx
-/-
comparison at P21. This table contains the full microarray datasets
from six microarray hybridizations (three biological replicates each
from wild-type (129S6/SvEv) and Crx
-/- retinas at P21). The data
from each of the individual microarray experiments are labeled
with the following prefixes: ‘Crx-mut_#1’ etc. and ‘129-wt-P21-
#1’ etc.
Found at: doi:10.1371/journal.pone.0000643.s009 (26.17 MB
XLS)
Table S6 Complete microarray datasets for wild-type vs. Crx
-/-;
Nrl
-/- comparison at P21. This table contains the full microarray
datasets from nine microarray hybridizations (three biological
replicates each from wild-type (C57BL/6), wild-type (129S6/
SvEv) and Crx
-/-; Nrl
-/- retinas at P21). Since Crx
-/-; Nrl
-/- is on
a mixed 129 X B6 background, we present comparisons between
both of the individual wild-type mutant backgrounds (as data from
the mixed control background were not available). The data from
each of the individual microarray experiments are labeled with the
following prefixes: ‘Crx-mut_#1’ etc., ‘B6-wt-P21-#1’ etc. and
‘129-wt-P21-#1’ etc.
Found at: doi:10.1371/journal.pone.0000643.s010 (39.54 MB
XLS)
Table S7 Intersection sets from Venn diagram analysis of
photoreceptor network. This table includes all possible intersec-
tions of sets of genes dysregulated in more than one of the three
single mutants: Crx
-/-, Nrl
-/-, and Nr2e3
-/-. For example, ‘Crx-
down > Nrl-down’ includes all genes which were downregulated
in both Crx
-/- and Nrl
-/- under high stringency criteria. The set
‘Nrl-down > Nrl-up’ includes one gene, Rs1h, which has two
corresponding Affy tags. One of these tags in downregulated in
Nrl
-/-, the other upregulated. These two tags possibly represent
variant transcriptional isoforms which are controlled differently by
Nrl.
Found at: doi:10.1371/journal.pone.0000643.s011 (0.03 MB
XLS)
Table S8 Transcription factors downstream of Crx, Nrl, and
Nr2e3. List of genes with Gene Ontology classification ‘transcrip-
tion factor activity’ derived from an analysis of the 628 genes
shown to be dysregulated in Crx
-/-, Nrl
-/-, and/or Nr2e3
-/- under
high stringency criteria. Those genes highlighted in light green are
thought to be sequence-specific TFs.
Found at: doi:10.1371/journal.pone.0000643.s012 (0.03 MB
XLS)
Table S9 Sequences of novel photoreceptor cis-regulatory
elements. This table includes the full DNA sequences of the 26
novel photoreceptor CREs characterized in this study along with
the sequences of the PCR primers used to obtain them. The
sequences of the mouse Rho-CRE as well as the control_ Rgs9-
CRE are also included. Restriction enzyme sites included in the
PCR primers for purposes of cloning are in upper case. Details
about the starting vectors and subcloning procedure are given in
Supplementary Methods.
Found at: doi:10.1371/journal.pone.0000643.s013 (0.04 MB
XLS)
Table S10 Complete datasets for three in silico evolutionary runs.
This spreadsheet includes three separate tabs corresponding to the
three independent evolutionary runs: Syn1, Syn2, and Syn3. Each
tab includes 1000 rows corresponding to the generations of the
experiment. For each generation the ‘fitness’ score and genome
sequence of the fittest ‘organism’ from that generation are given.
The organisms corresponding to the six synthetic CREs assayed
(i.e. Syn1-G70 etc.) are highlighted in light green.
Found at: doi:10.1371/journal.pone.0000643.s014 (0.97 MB
XLS)
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